Table: begin end state 1 24 non-cytoplasmic 25 43 transmembrane 44 65 cytoplasmic 66 87 transmembrane 88 93 non-cytoplasmic 94 116 transmembrane 117 155 cytoplasmic 156 177 transmembrane 178 182 non-cytoplasmic 183 201 transmembrane 202 247 cytoplasmic 248 272 transmembrane 273 285 non-cytoplasmic 286 310 transmembrane 311 321 cytoplasmic 322 340 transmembrane 341 345 non-cytoplasmic 346 367 transmembrane 368 376 cytoplasmic 377 401 transmembrane 402 407 non-cytoplasmic 408 430 transmembrane 431 438 cytoplasmic
Input: >BPHYT_RS20950 MKVVEEQTLSARNPAYADTTKRSKVRYVVLSMLLAATILNYVDRSALGIVAPGLSKGLAL DKMQMGELFAAFGLAYSIGLVPGGVLTDVLGSRVAYALSLLGWSFATLTQGLATGYHMLL GSRLAIGALEAPAFPSNARAVTLWFPARERGFATSVYVMGQYIGTPLFTGLLLWISAAYG WRMVFYVTGGVGILFSLFWYRVYRDPHQHASVNAAELQYINDGSTAARKPREKFDWRMAL KLLSYRQILAICVGKFCNNTLLVFFTTWFMTYLIEARHMSMIKVGIFQALPFIGATAGIL LAGSLSDFFIRRGVSISTARKTPLIVGTLLGASIVLVNFVESNEAVIAILTIAFFAQGVG SMSWAAVSEIAPRQYVGLTSSITSLAANIAGVTTPLMIGYITHHTGHFYWALNLMGAICL LGAFSYSVLLGKLSRIEL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server